Literature DB >> 2530286

The liposome-mediated macrophage 'suicide' technique.

N Van Rooijen1.   

Abstract

Macrophages form an important cell population involved in numerous immunological processes. Techniques which eliminate these cells, in order to permit 'in vivo' studies of their function are generally imperfect and for that reason we have developed a method using the liposome encapsulated drug dichloromethylene diphosphonate (Cl2MDP). The liposomes are ingested by the macrophages which are then destroyed following phospholipase-mediated disruption of the liposomal bilayers and release of the Cl2MDP. In the present review, technical details of the preparation of liposome encapsulated Cl2MDP are given, and applications of the technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530286     DOI: 10.1016/0022-1759(89)90178-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  122 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Activation of glucocorticoid receptors in Müller glia is protective to retinal neurons and suppresses microglial reactivity.

Authors:  Donika Gallina; Christopher Paul Zelinka; Colleen M Cebulla; Andy J Fischer
Journal:  Exp Neurol       Date:  2015-08-10       Impact factor: 5.330

3.  Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model.

Authors:  Jun Li; Hui-Chen Hsu; PingAr Yang; Qi Wu; Hao Li; Laura E Edgington; Matthew Bogyo; Robert P Kimberly; John D Mountz
Journal:  Arthritis Rheum       Date:  2011-10-13

4.  Alveolar macrophages down-regulate local pulmonary immune responses against intratracheally administered T-cell-dependent, but not T-cell-independent antigens.

Authors:  T Thepen; K Hoeben; J Brevé; G Kraal
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

5.  Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).

Authors:  A Benoit; Y Huang; J Proctor; G Rowden; R Anderson
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 6.  Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.

Authors:  R M Fielding
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

7.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae.

Authors:  Victor I Band; Emily K Crispell; Brooke A Napier; Carmen M Herrera; Greg K Tharp; Kranthi Vavikolanu; Jan Pohl; Timothy D Read; Steven E Bosinger; M Stephen Trent; Eileen M Burd; David S Weiss
Journal:  Nat Microbiol       Date:  2016-05-09       Impact factor: 17.745

9.  Alveolar macrophages from allergic lungs are not committed to a pro-allergic response and can reduce airway hyperresponsiveness following ex vivo culture.

Authors:  P Pouliot; A Spahr; E Careau; V Turmel; E Y Bissonnette
Journal:  Clin Exp Allergy       Date:  2008-01-14       Impact factor: 5.018

10.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.

Authors:  D Ben-Nathan; I Huitinga; S Lustig; N van Rooijen; D Kobiler
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.